Search results for #ASH23
Been focused on #autoimmune but should remember #ASH23 and $CRVS novel MoA reversing T-cell exhaustion for fighting cancer #oncology #cancer
Been focused on #autoimmune but should remember #ASH23 and $CRVS novel MoA reversing T-cell exhaustion for fighting cancer #oncology #cancer
Microcapsule review of everything #geriheme at #ASH23 @ASH_hematology Thank you @YoungSIOG @SIOGorg @JGeriOnc for the opportunity to publish this collaboration.
Microcapsule review of everything #geriheme at #ASH23 @ASH_hematology Thank you @YoungSIOG @SIOGorg @JGeriOnc for the opportunity to publish this collaboration.
@AbdelWahablab @MolecularCell @bradleybio @Doulatov_lab @SBenbarche @jpineda223 @GalvisBaquero Congrats Salima @SBenbarche, Omar @AbdelWahablab, Robert @bradleybio, and all authors! Really great work and enjoyed the talk at #ASH23!
Access free #ASH23 DEI content 💻 Topics include: Outcome Disparities in Hematologic Diseases: The Importance of Social Determinants in Health How to Support LGBTQIA Patients, Trainees, and Colleagues: A Whole Person Perspective And more: ow.ly/1vrW50RiwcT #NMHM24
With all the CD19 I&I hype I'm sure glad I listened to this Dec. 2023 #ASH23 Schett presentation $CABA $CGEM $ELYM $NKTX $FATE $ALLO $IGMS $ACET
Finally, we time-traveled back to #ASH23 to talk about Leslie Kean @DanaFarber and colleagues' epic analysis of the @BMTCTN #CTN1801 data describing the differences in T-cell diversity and repertoire between TAC/MTX and PTCy recipients ash.confex.com/ash/2023/webpr… 4/n
It’s AML World Awareness Day! 🩸 Check out our interview w/ @CLachowiez from #ASH23, who discusses promising combination approaches for overcoming venetoclax resistance in AML: 👉 ow.ly/U5Eh50R3kfh #Leusm #AMLsm #HemOnc
Remember the #ASH23 excitement? Feel it year-round by volunteering with ASH! ⭐ Step 1️⃣ complete the volunteer interest form to get matched with the right opportunity. 📝Simply click the link and sign in or create your account: ow.ly/L1em50Rcefy #NationalVolunteerMonth
Check out our review of high-impact #geriheme & #gerionc abstracts from @ASH_hematology #ASH23, now published @JGeriOnc. Patient-reported outcomes abstracts are also featured! sciencedirect.com/science/articl…
Check out our @YoungSIOG position paper highlighting some of the #geriheme research presented at #ASH23! Thankful for this dream team ✨ of co-authors Drs. O. Akhtar, @MazieTsangMD @HiraSMian @majorajay @PallawiTorkaMD! @ASH_hematology @JGeriOnc @myCARG @GeriOncCoP @SIOGorg
Check out our @YoungSIOG position paper highlighting some of the #geriheme research presented at #ASH23! Thankful for this dream team ✨ of co-authors Drs. O. Akhtar, @MazieTsangMD @HiraSMian @majorajay @PallawiTorkaMD! @ASH_hematology @JGeriOnc @myCARG @GeriOncCoP @SIOGorg
Out now in @JGeriOnc Easy to read, concise summary of high value data on #geriheme #gerionc at #ASH23 sciencedirect.com/science/articl… Thanks @YoungSIOG @SIOGorg for the opportunity. Kudos @MayaAbdallah_MD, Othman Akhtar, @HiraMian @MazieTsangMD @majorajay for the excellent collab.
MDS: Transfusion Independence Across Different Risk Subgroups in IMerge Phase 3 Trial #ASH23 | @dgsomucla targetedonc.com/view/mds-trans…
@ProfMakris @BloodJournal One of my favorite #ASH23 sessions that we also included in our highlights of ash programming!
For those of you who missed my program on the latest myeloma treatments: Answers Now: Multiple Myeloma Updates @ancan501c3 @DrBlueMD #MultipleMyeloma #MGUS #ASH23 #myeloma patientpower.info/multiple-myelo…
🌟 ¡Solo faltan dos semanas! Del 19 al 20 de abril, en Medellín, reuniremos a los principales hematólogos y profesionales del área en el 2024 Highlights of ASH® in Latin America🩸✨ Inscríbete hoy a través del enlace: hematology.org/meetings/highl… #ASH23 #ASH #ACHO #Hematologia
🌟 Faltam duas semanas para o 2024 Highlights of ASH®️ in Latin Americal! Hoje (5 de abril) é o último dia para garantir sua inscrição antecipada. 🩸 Aproveite até 37% de desconto ao se inscrever ainda hoje: ow.ly/iKBu50R8UQV #ASH23 #ASH #ACHO #Hematologia